Factors associated with delayed presentation to healthcare facilities for Lassa fever cases, Nigeria 2019: a retrospective cohort study

BACKGROUND: Large outbreaks of Lassa fever (LF) occur annually in Nigeria. The case fatality rate among hospitalised cases is ~ 20%. The antiviral drug ribavirin along with supportive care and rehydration are the recommended treatments but must be administered early (within 6 days of symptom onset)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:BMC Infect Dis
Main Authors: Chandra, Nastassya L., Bolt, Hikaru, Dan-Nwafor, Chioma, Ipadeola, Oladipupo, Ilori, Elsie, Namara, Geoffrey, Olayinka, Adebola T., Ukponu, Winifred, Iniobong, Akanimo, Amedu, Michael, Akano, Adejoke, Akabike, Kachikwulu O., Okhuarobo, Uwaifiokun, Fagbemi, Stephen, Sampson, Emeka, Newitt, Sophie, Verlander, Neville Q., Bausch, Daniel G., le Polain de Waroux, Olivier, Ihekweazu, Chikwe
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2021
Assuntos:
Research Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7863257/
https://ncbi.nlm.nih.gov/pubmed/33541278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12879-021-05822-4
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares